These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 27834303

  • 1. Single nucleotide polymorphisms and genotypes of transient receptor potential ion channel and acetylcholine receptor genes from isolated B lymphocytes in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Marshall-Gradisnik S, Johnston S, Chacko A, Nguyen T, Smith P, Staines D.
    J Int Med Res; 2016 Dec; 44(6):1381-1394. PubMed ID: 27834303
    [Abstract] [Full Text] [Related]

  • 2. Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome.
    Marshall-Gradisnik S, Huth T, Chacko A, Johnston S, Smith P, Staines D.
    Appl Clin Genet; 2016 Dec; 9():39-47. PubMed ID: 27099524
    [Abstract] [Full Text] [Related]

  • 3. A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Johnston S, Staines D, Klein A, Marshall-Gradisnik S.
    BMC Med Genet; 2016 Nov 11; 17(1):79. PubMed ID: 27835969
    [Abstract] [Full Text] [Related]

  • 4. Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients.
    Nguyen T, Staines D, Nilius B, Smith P, Marshall-Gradisnik S.
    Biol Res; 2016 May 31; 49(1):27. PubMed ID: 27245705
    [Abstract] [Full Text] [Related]

  • 5. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
    Cabanas H, Muraki K, Balinas C, Eaton-Fitch N, Staines D, Marshall-Gradisnik S.
    Mol Med; 2019 Apr 23; 25(1):14. PubMed ID: 31014226
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.
    Cabanas H, Muraki K, Eaton-Fitch N, Staines DR, Marshall-Gradisnik S.
    Front Immunol; 2021 Apr 23; 12():687806. PubMed ID: 34326841
    [Abstract] [Full Text] [Related]

  • 8. Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels.
    Nguyen T, Johnston S, Clarke L, Smith P, Staines D, Marshall-Gradisnik S.
    Clin Exp Immunol; 2017 Feb 23; 187(2):284-293. PubMed ID: 27727448
    [Abstract] [Full Text] [Related]

  • 9. Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Eaton-Fitch N, Du Preez S, Cabanas H, Muraki K, Staines D, Marshall-Gradisnik S.
    J Transl Med; 2022 Feb 16; 20(1):94. PubMed ID: 35172836
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of single-nucleotide polymorphisms (SNPs) to distinguish gene expression subtypes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).
    Shimosako N, Kerr JR.
    J Clin Pathol; 2014 Dec 16; 67(12):1078-83. PubMed ID: 25240059
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Altered TRPM7-Dependent Calcium Influx in Natural Killer Cells of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
    Du Preez S, Eaton-Fitch N, Smith PK, Marshall-Gradisnik S.
    Biomolecules; 2023 Jun 26; 13(7):. PubMed ID: 37509075
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Herrera S, de Vega WC, Ashbrook D, Vernon SD, McGowan PO.
    Epigenetics; 2018 Jun 26; 13(12):1174-1190. PubMed ID: 30516085
    [Abstract] [Full Text] [Related]

  • 17. The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP2 and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Eaton-Fitch N, Cabanas H, du Preez S, Staines D, Marshall-Gradisnik S.
    J Transl Med; 2021 Jul 15; 19(1):306. PubMed ID: 34266470
    [Abstract] [Full Text] [Related]

  • 18. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
    Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Wong N, Ramos S, Staines D, Marshall-Gradisnik S.
    BMC Immunol; 2015 Jun 02; 16():35. PubMed ID: 26032326
    [Abstract] [Full Text] [Related]

  • 19. Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset.
    Steiner S, Becker SC, Hartwig J, Sotzny F, Lorenz S, Bauer S, Löbel M, Stittrich AB, Grabowski P, Scheibenbogen C.
    Front Immunol; 2020 Jun 02; 11():578. PubMed ID: 32328064
    [Abstract] [Full Text] [Related]

  • 20. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Huth TK, Staines D, Marshall-Gradisnik S.
    J Transl Med; 2016 Apr 21; 14():97. PubMed ID: 27098723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.